Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a shingles shot protect transplant patients? new study investigates timing

NCT ID NCT05775718

First seen Feb 05, 2026 · Last updated May 22, 2026 · Updated 18 times

Summary

This study looks at how well the shingles vaccine (Shingrix) works in people who have had a stem cell transplant. Researchers want to find the best time to give the vaccine after transplant and whether a third dose helps. About 55 adults who already received two doses of Shingrix at least a year after transplant will join. The goal is to make sure these patients get strong protection against shingles.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STEM CELL TRANSPLANT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Colorado Hospital

    RECRUITING

    Aurora, Colorado, 80045, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.